SCHEMBL20959095

SCHEMBL20959095

O=C1c2ccccc2C(=O)N1[C@@H]1CCCC[C@H]1Oc1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.44
▸ CYP1A2 P05177 2/20 0.42
▸ GRM5 P41594 1/20 0.42
▸ FURIN P09958 1/20 0.39
▸ HCRTR2 O43614 3/20 0.39
▸ MAPT P10636 3/20 0.36
▸ HTT P42858 1/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ HPGD P15428 3/20 0.36
▸ PKM P14618 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ MC4R P32245 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CHRM2 P08172 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ DDB1 Q16531 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20959527 0.82 ALDH1A1 (0.35) ALDH1A1CYP1A2GRM5HCRTR2MAPT
Hydrochloric Acid SCHEMBL28713483 0.81 FURIN (0.37) ALDH1A1CYP1A2GRM5FURINHCRTR2
Hydrochloric Acid SCHEMBL31144002 0.81 FURIN (0.37) ALDH1A1CYP1A2GRM5FURINHCRTR2
SCHEMBL20959453 0.78 MEN1 (0.46) ALDH1A1MAPTHPGDKMT2AALOX12
SCHEMBL31144052 0.73 HCRTR2 (0.38) HCRTR2TSHRHCRTR1
SCHEMBL28701004 0.73 HCRTR2 (0.38) HCRTR2TSHRHCRTR1
SCHEMBL20958747 0.72 FURIN (0.49) CYP1A2GRM5FURINHCRTR2PKM
SCHEMBL18973309 0.72 ALDH1A1 (0.41) ALDH1A1CYP1A2MAPTHSD17B10HPGD
SCHEMBL5857725 0.69 FURIN (0.50) ALDH1A1CYP1A2GRM5FURINHCRTR2
SCHEMBL2691952 0.69 LOX (0.50) FURIN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111032651-A Heterocyclic compounds 武田药品工业株式会社 2020-04-17 — — CN disclosed
US-10435399-B2 HDAC6 inhibitory heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-10-08 — — US disclosed
US-20190135799-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10435399-B2 HDAC6 inhibitory heterocyclic compound HDAC6, HDAC1, HDAC5 ALDH1A1 400/4885CYP1A2 3883/4885GRM5 221/4885
US-20190135799-A1 HETEROCYCLIC COMPOUND HDAC1, HDAC5, HDAC6 ALDH1A1 417/4885CYP1A2 2387/4885GRM5 144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback